Heart Type Fatty Acid Binding Protein (H-FABP) is an early marker or acute cardiac syndrome.
During 2016, HyTest was able to achieve a record high growth in sales. Consolidated revenues grew by 37.6% to a total of 23.8 million euros.
29.03.2017 Jessi the Customs dog
Jessi the Customs dog is now Jessi the Family dog.
27.02.2017 Meet us at CACLP Expo
HyTest participates in the China Association of Clinical Laboratory Practice Expo held in Qingdao International Convention Center, 12 – 14, March.
21.02.2017 Sponsoring a new EFLM Award
We are delighted to let you know that we are sponsoring the EFLM-HyTest Cardiac Marker Award for remarkable scientific work in the field of cardiovascular diseases.
31.01.2017 Meet us at NAVC Conference
We will be present at the The NAVC Veterinary Conference, which is held in Orange County Convention Center West Concourse Orlando during February 4-8.
Hypothyroidism is one of the most common endocrine disorders in dogs. The diagnosis is carried out based on both clinical signs and various diagnostic tests.
Noroviruses are highly contagious viruses that cause acute gastroenteritis and the source of infection is often contaminated food or water. Norovirus infections spread quickly and outbreaks affecting hundreds of people are common.
11.01.2017 HyTest Wins Annual Export Prize
Turku Chamber of Commerce chose HyTest as a winner of the annual Export Prize 2016.
The presence of cardiac troponin I autoantibodies in blood has been known for a long time. These autoantibodies bind to the stable part of cTnI and may be found in the blood of both healthy people...
19.12.2016 Season's Greetings 2016
We appreciate working with you and hope that the holidays and the coming year will bring you happiness and success.
30.11.2016 Sponsoring SensUs 2017
New innovations in biosensing technologies are critical for driving the development of diagnostic systems towards small, easy-to-use systems that allow versatile ways to monitor different biomarkers.
BNP is an established biomarker widely used for heart failure diagnostics. Several companies provide immunoassays that enable quantitative detection of circulating BNP.
26.10.2016 About Entresto™ and immunoreactive BNP
A short article “Can we expect a pronounced effect of neprilysin inhibition by LCZ696 on the levels of immunoreactive BNP? ” written by Dr. Alexander Semenov, one of HyTest’s scientists, was published in NACB Scientific Shorts in October.
26.10.2016 Sponsoring a new IFCC Award
We are delighted to let you know that we are sponsoring the new IFCC Distinguished Award for Contributions to Cardiovascular Diagnostics. The award honors an individual who has undertaken remarkable scientific work with cardiac markers or immunodiagnostic applications to improve cardiac disease diagnosis.
25.10.2016 HyTest Attends Medica 2016 in November
HyTest participates in Medica exhibition in November. If you or your colleagues will attend the MEDICA 2016 - the World's Leading Medical Forum - from November 14 to 17, in Düsseldorf, Germany, please schedule a meeting with us.
29.09.2016 Supporting the dogs of Finnish Customs
HyTest is supporting Finnish Customs by sponsoring its dogs.
Our researchers presented four posters at the EFLM-UEMS Congress recently held in Warsaw, Poland.
29.09.2016 Paul White joins the HyTest Board
We are delighted to announce that Mr. Paul White has joined the HyTest Board of Directors with effect from September 2016.
During the first half of 2016, HyTest was able to continue its strong growth. Its...